MICAL2 is widely expressed in various cancers, including glioblastoma (25), prostate cancer (26), bladder cancer (25), etc. MICAL2 participates in cell growth, cell apoptosis, axon guidance, and the transportation of vesicles by controlling the assembly and disassembly of actin (26, 27). This evidence concerns the gene MICAL2 and urinary bladder cancer.